Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The ESSENCE trial 240-week readout in 2028 will be a landmark, but longer follow-up and adequately powered studies in higher-risk populations (F3-F4 fibrosis) remain priorities
Zealand Pharma and Boehringer Ingelheim are working on two dual agonists dapiglutide and survodutide (BI 456906) that are in phase 2 trials for weight loss
Epitalon/Epithalon peptide Not For Human Use, Lab Use Only
GSH is the only biologically active form of glutathione in the human body that exerts functions such as antioxidant, detoxification, and immune support
US$ 28.04
US$ 20.78
US$ 28.81
US$ 23.66
US$ 25.53
